Marcus R. Makowski

Technical University of Munich

Papers

1

Total Citations

13

H-Index

1

About

Marcus R. Makowski is a leading figure in hybrid molecular imaging, with a focused expertise in the application of PET/MRI for neuro-oncology and rare tumor entities. His work centers on leveraging receptor-based imaging agents to improve diagnostic precision and treatment planning. A hallmark contribution is his pioneering research on 68Ga-DOTATOC-PET/MRI for optic nerve sheath meningiomas (ONSM), demonstrating how this "one-stop shop" hybrid tool can enhance tumor delineation through somatostatin receptor binding, directly informing robotic radiosurgery planning. This work, cited 13 times, addresses a critical gap in managing ONSM, a rare condition that can cause irreversible blindness. By proving the feasibility of receptor-based hybrid imaging in this challenging context, Makowski has advanced the paradigm of personalized, image-guided therapy for complex intracranial tumors. His research underscores the transformative potential of combining metabolic and anatomical data to optimize patient outcomes, establishing him as an innovator at the intersection of radiology, nuclear medicine, and neurosurgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
68Ga-DOTATOC-PET/MRI—A Secure One-Stop Shop Imaging Tool for Robotic Radiosurgery Treatment Planning in Patients with Optic Nerve Sheath Meningioma
13 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Technical University of Munich

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago